Trial Profile
Phase III study of Topsalysin in Benign-prostatic-hyperplasia.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 11 Jun 2018
Price :
$35
*
At a glance
- Drugs Topsalysin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Sophiris Bio
- 11 Jun 2018 New trial record